Radiolabeled SMT-487 (Yttrium-90-DOTA-Tyr3-octreotide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Radiolabeled SMT-487 (Yttrium-90-DOTA-Tyr3-octreotide), covering 2013-05-01 to 2013-05-01. Get the full timeline:
Most recent: Clinical Trial Update: Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer [Phase 2]